Drug
Tenapanor Bid
Tenapanor Bid: highest development phase Phase 3, developed by Ardelyx. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Ardelyx
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tenapanor 5 mg BID NCT07382167 | Phase 3 | Chronic Idiopathic Constipation (CIC) |
Latest
No recent events.
Follow Tenapanor Bid on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.